JNM CE/SAM (December 2017): 18F-FDG PET in Parkinsonism: Differential Diagnosis and Evaluation of Cognitive Impairment

JNM, December 2017, Volume 58, Number 12

Release Date: 12/1/2017
Expiration Date: 12/31/2020

SNMMI Members: Free
Non-Members: $69.00

Continuing Education Credit Information

ABNM SAM Credit
The American Board of Nuclear Medicine has reviewed and approved this Journal SAM activity submitted by the SNMMI. This activity fulfills the requirements of the ABNM Maintenance of Certification program for self-assessment. 2.0 SAMs have been awarded for this activity.

AMA-PRA (Physician)
The Society for Nuclear Medicine and Medical Imaging, Inc. (SNMMI) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. SNMMI designates this enduring material for a maximum of 2.0 AMA PRA Category 1 CreditsTM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Objectives
On successful completion of this activity, participants should be able to describe…
1. Describe the clinical demand and rationale for differential diagnosis in parkinsonism.
2. Recognize and differentiate the disease-specific patterns of regional glucose metabolism associated with Parkinson disease (PD) and the different atypical parkinsonian syndromes (APSs).
3. Identify regional metabolic changes that predict cognitive decline in PD.

Target Audience
This article contains information of value to nuclear medicine physicians and technologists, as well as to neurologists.

Authors
Philipp T. Meyer1, Lars Frings1,2, Gerta Rücker3, and Sabine Hellwig4
1Department of Nuclear Medicine, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 2Center for Geriatrics and Gerontology, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; 3Institute for Medical Biometry and Statistics, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany; and 4Department of Psychiatry, Medical Center – University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany

Disclosure
Dr. Meyer receives support from GE and Piramal for a research study outside the present topic. In accordance with ACCME Revised Standards for Commercial Support and SNMMI Conflict-of-Interest Policy, the authors have indicated no other relevant relationships that could be perceived as a real or apparent conflict of interest. Disclosure of a relationship is not intended to suggest or to condone bias but is made to provide participants with information that might be of potential importance to their evaluation of the activity.

Contact Information
For questions please contact Lisa Dickinson, Associate Director of Education at ldickinson@snmmi.org or 703-652-6783.